Dasatinib inhibits coated-platelet generation in patients with chronic myeloid leukemia
Sign Up to like & getrecommendations! Published in 2018 at "Platelets"
DOI: 10.1080/09537104.2018.1501470
Abstract: Abstract Since the introduction of tyrosine kinase inhibitors, the overall survival of patients with chronic myeloid leukemia has markedly improved. However long term use of these drugs results in various adverse events. Treatment with second… read more here.
Keywords: coated platelet; dasatinib; patients chronic; platelet generation ... See more keywords